Print page content Print
Increase text size Decrease text size
Text Size

motion sickness calendar

Prevent Emesis as Long as Needed

CERENIA® (maropitant citrate) Tablets are approved for use until resolution of acute vomiting in dogs 7 months and older.

Steady State Levels Reached by Day Four in 14-day Pharmacokinetics Study16

In a 14-day repeat dose pharmacokinetics study in laboratory dogs, the time to reach steady state levels of maropitant metabolite was approximately 4 days for daily 2 mg/kg oral dosing. Steady state pharmacokinetics confirms that the rate of drug accumulation equals the rate of drug elimination.

Graph shows steady-state levels of maropitant 2 mg/kg dosage reached by day 4 of pharmacokinetics study

Extended Dosing Safety

In a laboratory safety study, 24 dogs 7 months of age were randomized into four groups of equal genders and given maropitant at O, 1, 5 or 2O mg/kg/day, once daily for 93 days. In the 2O mg/kg/day group, sporadic clinical signs (salivation, emesis), body weight loss and lower serum albumin levels, as well as increased P-R interval, P wave duration and QRS amplitude were noted. These effects were not noted in the other dosing groups.

Graphic shows dog and 2 mg/kg dosage with check mark indicating study support for dosage

This study supports the safe use of maropitant citrate at a dose of 2mg/kg (O.9 mg/lb) body weight once daily as long as needed.



Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.